p300 Acetyltransferase Is a Cytoplasm‐to‐Nucleus Shuttle for SMAD2/3 and TAZ Nuclear Transport in Transforming Growth Factor β–Stimulated Hepatic Stellate Cells
Yuanguo Wang,Kangsheng Tu,Donglian Liu,Luyang Guo,Yunru Chen,Qing Li,Jessica L. Maiers,Zhikui Liu,Vijay H. Shah,Changwei Dou,Daniel Tschumperlin,Luke Voneschen,Rendong Yang,Ningling Kang
DOI: https://doi.org/10.1002/hep.30668
IF: 17.298
2019-05-23
Hepatology
Abstract:<p>Nuclear translocation of SMAD2/3, core transcription factors of TGFβ signaling, is critical for hepatic stellate cell (HSC) differentiation into metastasis‐promoting myofibroblasts. SMAD2/3 have multiple coactivators, including WW domain‐containing transcription regulator protein 1 (WWTR1 or TAZ) and p300 acetyltransferase. In the nucleus, TAZ binds to SMAD2/3 to prevent SMAD2/3 nuclear export. However, how TAZ and SMAD2/3 enter the nucleus remains poorly understood because neither contains a nuclear localization signal (NLS), an amino acid sequence tagging proteins for nuclear transport. P300 is a NLS‐containing large scaffold protein so we hypothesized that SMAD2/3 and TAZ may undergo nuclear import through complexing with p300. Coimmunoprecipitation, immunofluorescence, and nuclear fractionation assays revealed that TGFβ1 promoted binding of SMAD2/3 and TAZ to p300 and that p300 inactivation disrupted TGFβ1‐mediated SMAD2/3 and TAZ nuclear accumulation. Deleting the p300 NLS blocked TGFβ1‐induced SMAD2/3 and TAZ nuclear transport. Consistently, p300 inactivation suppressed TGFβ1‐mediated HSC activation and transcription of genes encoding tumor‐promoting factors, such as CTGF, TNC, POSTN, PDGFC, and FGF2, as revealed by microarray analysis. ChIP‐qPCR showed that canonical p300‐mediated acetylation of histones also facilitated transcription in response to TGFβ1 stimulation. Interestingly, although both TGFβ1‐ and stiffness‐mediated HSC activation require p300, comparison of gene expression datasets revealed that transcriptional targets of TGFβ1 were distinct from those of stiffness‐p300 mechanosignaling. Lastly, in tumor/HSC coinjection and intrasplenic tumor injection models, targeting p300 of activated‐HSC/myofibroblasts by C646, shRNA, or <i>cre</i>‐mediated gene disruption reduced tumor and liver metastatic growth in mice. </p><h3> Conclusion</h3><p>P300 facilitates TGFβ1‐stimulated HSC activation by both non‐canonical (cytoplasm‐to‐nucleus shuttle for SMAD2/3 and TAZ) and canonical (histone acetylation) mechanisms. P300 is an attractive target for inhibiting HSC activation and the prometastatic liver microenvironment.</p><p>This article is protected by copyright. All rights reserved.</p>
gastroenterology & hepatology